These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20232510)

  • 21. Attention-deficit/hyperactivity disorder: increased costs for patients and their families.
    Swensen AR; Birnbaum HG; Secnik K; Marynchenko M; Greenberg P; Claxton A
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1415-23. PubMed ID: 14627876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Burden of illness and health care resource utilization in adult psychiatric outpatients with attention-deficit/hyperactivity disorder in Europe.
    Karlsdotter K; Bushe C; Hakkaart L; Sobanski E; Kan CC; Lebrec J; Kraemer S; Dieteren NA; Deberdt W
    Curr Med Res Opin; 2016 Sep; 32(9):1547-56. PubMed ID: 27171913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of attention-deficit/hyperactivity disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence.
    Schlander M
    Child Adolesc Psychiatry Ment Health; 2007 Nov; 1(1):13. PubMed ID: 18005403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The prevalence of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents in Germany. Initial results from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)].
    Schlack R; Hölling H; Kurth BM; Huss M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007; 50(5-6):827-35. PubMed ID: 17514469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective.
    Schein J; Adler LA; Childress A; Cloutier M; Gagnon-Sanschagrin P; Davidson M; Kinkead F; Guerin A; Lefebvre P
    J Med Econ; 2022; 25(1):193-205. PubMed ID: 35068300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mothers of children diagnosed with attention-deficit/hyperactivity disorder: health conditions and medical care utilization in periods before and after birth of the child.
    Ray GT; Croen LA; Habel LA
    Med Care; 2009 Jan; 47(1):105-14. PubMed ID: 19106738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [INTEGRATE-ADHD: Comparison and Integration of Administrative and Epidemiological ADHD Diagnosis Data through Clinical Assessment - Presentation of the Project].
    Schlack R; Beyer AK; Beck L; Hölling H; Pfeifer S; Romanos M; Jans T; Hetzke L; Berner A; Weyrich S; Scholz V; Ravens-Sieberer U; Kaman A; Gilbert M; Reiß F; Greiner W; Witte J; Hasemann L; Heuschmann P; Fiessler C; Widmann J; Riederer C
    Gesundheitswesen; 2024 Jul; 86(S 03):S231-S237. PubMed ID: 39074803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity.
    Ray GT; Levine P; Croen LA; Bokhari FA; Hu TW; Habel LA
    Arch Pediatr Adolesc Med; 2006 Oct; 160(10):1063-9. PubMed ID: 17018466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder.
    Telford C; Green C; Logan S; Langley K; Thapar A; Ford T
    Soc Psychiatry Psychiatr Epidemiol; 2013 Feb; 48(2):337-44. PubMed ID: 22699685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD).
    Hakkaart-van Roijen L; Zwirs BW; Bouwmans C; Tan SS; Schulpen TW; Vlasveld L; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2007 Aug; 16(5):316-26. PubMed ID: 17483870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
    Albert M; Rui P; Ashman JJ
    NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD.
    Lachaine J; Sikirica V; Mathurin K
    BMC Psychiatry; 2016 Jan; 16():11. PubMed ID: 26774811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic implications of attention-deficit hyperactivity disorder for healthcare systems.
    Leibson CL; Long KH
    Pharmacoeconomics; 2003; 21(17):1239-62. PubMed ID: 14986737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
    Pelham WE; Foster EM; Robb JA
    J Pediatr Psychol; 2007 Jul; 32(6):711-27. PubMed ID: 17556402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment costs of attention deficit hyperactivity disorder in Germany.
    Braun S; Zeidler J; Linder R; Engel S; Verheyen F; Greiner W
    Eur J Health Econ; 2013 Dec; 14(6):939-45. PubMed ID: 23179162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The attention-deficit hyperactivity disorder paradox: 2. Phenotypic variability in prevalence and cost of comorbidity.
    Burd L; Klug MG; Coumbe MJ; Kerbeshian J
    J Child Neurol; 2003 Sep; 18(9):653-60. PubMed ID: 14572145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD.
    Jensen PS; Garcia JA; Glied S; Crowe M; Foster M; Schlander M; Hinshaw S; Vitiello B; Arnold LE; Elliott G; Hechtman L; Newcorn JH; Pelham WE; Swanson J; Wells K
    Am J Psychiatry; 2005 Sep; 162(9):1628-36. PubMed ID: 16135621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health Care Costs Associated With Parent-Reported ADHD: A Longitudinal Australian Population-Based Study.
    Sciberras E; Lucas N; Efron D; Gold L; Hiscock H; Nicholson JM
    J Atten Disord; 2017 Nov; 21(13):1063-1072. PubMed ID: 23816972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outpatient rehabilitation utilization and medical expenses in children aged 0-7 years with ADHD: analyses of population-based national health insurance data.
    Lin JD; Chen YH; Lin LP
    Res Dev Disabil; 2013 Jul; 34(7):2127-32. PubMed ID: 23643766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.